-
-
-
-
-
-
-
Progenics Pharmaceuticals Announces Business Update And Third Quarter 2019 Financial Results
-
-
-
-
-
-
-
Progenics Pharmaceuticals Announces Additional Governance Enhancements
-
-
-
-
-
-
-
Velan Calls for Increased Transparency at Progenics Pharmaceuticals During Q1 Earnings Call
-
-
-
-
-
-
-
Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2018 Financial Results and Business Update
-
-
-
-
-
-
-
Progenics Pharmaceuticals Sets Third Quarter 2018 Financial Results and Business Update Call for November 8
-
-
-
-
-
-
-
Progenics Pharmaceuticals Announces FDA Approval for AZEDRA® (iobenguane I 131) to Treat Unresectable, Locally Advanced or Metastatic Pheochromocytoma or Paraganglioma
-
-
-
-
-
-
-
Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2017 Financial Results and Business Update
-
974,852 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All